{"id":3302050,"date":"2025-08-29T17:53:43","date_gmt":"2025-08-29T15:53:43","guid":{"rendered":"http:\/\/nhub.news\/?p=3302050"},"modified":"2025-08-30T08:42:50","modified_gmt":"2025-08-30T06:42:50","slug":"trumps-new-cdc-chief-a-washington-health-insider-with-a-libertarian-streak","status":"publish","type":"post","link":"http:\/\/nhub.news\/fr\/2025\/08\/trumps-new-cdc-chief-a-washington-health-insider-with-a-libertarian-streak\/","title":{"rendered":"Trump\u2019s new CDC chief: A Washington health insider with a libertarian streak"},"content":{"rendered":"<p style=\"text-align: justify;\"><b>President Donald Trump has picked Jim O\u2019Neill, a former investor and critic of health regulations serving under Health Secretary Robert F. Kennedy Jr., to take control of the CDC, following a tumultuous week in which the agency&rsquo;s director was forced out.<\/b><br \/>\nPresident Donald Trump has picked Jim O\u2019Neill, a former investor and critic of health regulations serving under Health Secretary Robert F. Kennedy Jr., to take control of the Centers for Disease Control and Prevention, following a tumultuous week in which the agency\u2019s director was forced out.<br \/>O\u2019Neill, Kennedy\u2019s deputy at the Department of Health and Human Services, will supplant Susan Monarez, a longtime government scientist who had been the CDC director for less than a month.<br \/>Monarez\u2019s lawyers said she refused \u201cto rubber-stamp unscientific, reckless directives and fire dedicated health experts.\u201d<br \/>O\u2019Neill takes over as acting director of an agency that has been rocked by firings, resignations and efforts by Kennedy to reshape the nation\u2019s vaccine policies to match his long-standing suspicions about the safety and effectiveness of long-established shots.<br \/>An HHS spokesperson said Friday that O\u2019Neill would continue to serve as deputy of the department but did not provide details on his new role.<br \/>A former associate of billionaire tech entrepreneur Peter Thiel, O\u2019Neill previously helped run one of Thiel\u2019s investment funds and later managed several of his other projects. Those included a nonprofit working to develop manmade islands that would float outside U.S. territory, allowing them to experiment with new forms of government.<br \/>He has no training in medicine or health care and holds bachelor\u2019s and master\u2019s degrees in humanities.A Washington insider on a team of outsiders<br \/>O\u2019Neill has kept a markedly lower profile than Trump\u2019s other top health officials, who all joined the administration as Washington outsiders. He\u2019s also the only one with experience working at HHS, where he served for six years under President George W. Bush.<br \/>Those who know him say he\u2019ll likely be tasked with trying to calm the situation at CDC \u2014 though it\u2019s unclear what, if any, independence he\u2019ll have from Kennedy.<br \/>\u201cJim O\u2019Neill is a health care policy professional and I don\u2019t think anybody can accuse him of being an RFK Jr. sock puppet,\u201d said Peter Pitts, a former FDA official under Bush. \u201cThe question becomes whether the role of CDC director becomes a strictly paper tiger position, where the person only does what they\u2019re told to by the secretary.\u201d<br \/>O\u2019Neill is not closely associated with Kennedy\u2019s \u201cMake America Healthy Again\u201d movement and its efforts against food dyes, fluoride and ultraprocessed foods.<br \/>He was also not a major critic of public health measures during the pandemic, unlike Food and Drug Administration chief Marty Makary and other Trump officials. Although O\u2019Neill did use social media to criticize FDA efforts to stop the prescribing of unproven treatments for COVID-19, including the anti-parasite drug ivermectin.O\u2019Neill has pushed for less regulation<br \/>O\u2019Neill has long-standing ties to the libertarian wing of the Republican Party, including Thiel, one of Trump\u2019s leading supporters from Silicon Valley. Like Thiel, O\u2019Neill has expressed disdain for many parts of the federal bureaucracy, saying it hinders advances in medicine, technology and other areas.<br \/>During Trump\u2019s first term, O\u2019Neill was vetted as a possible choice to lead the FDA, although his past statements about the agency raised alarms among pharmaceutical and medical technology executives.<br \/>In particular, O\u2019Neill proposed doing away with FDA\u2019s 60-year-old mandate of assuring new drugs are both safe and effective in treating disease. In a 2014 speech, O\u2019Neill suggested drug effectiveness could be established after they hit the market.<br \/>Trump ultimately nominated Dr. Scott Gottlieb, a former FDA official and supporter of the agency\u2019s regulatory approach, as commissioner.Refusal to break with Kennedy on vaccines<br \/>After being nominated to the HHS post, O\u2019Neill voiced his support for the federal government\u2019s traditional system for overseeing vaccines \u2014 including the role of the CDC \u2014 while refusing to criticize Kennedy\u2019s views on the topic.<br \/>\u201cI support CDC\u2019s recommendations for vaccines,\u201d O\u2019Neill told Louisiana Republican Sen. Bill Cassidy at a confirmation hearing in June. \u201cI think that\u2019s a central role that CDC has. It\u2019s mandated in law.\u201d<br \/>In follow-up questions, ranking Democrat Ron Wyden pressed O\u2019Neill on statements by Kennedy downplaying the safety and effectiveness of vaccines to prevent measles and other diseases.<br \/>\u201cSecretary Kennedy has not made it difficult nor discouraged people from taking vaccines,\u201d O\u2019Neill responded.High-stakes vaccine decisions ahead<br \/>Within weeks, O\u2019Neill could be asked to sign off on new recommendations from a CDC panel that Kennedy has reshaped with vaccine skeptics. The group is scheduled to meet next month to review vaccinations for measles, hepatitis and other conditions that have long been established on the government schedule for children.<br \/>Traditionally, the CDC director signs off on recommendations from the panel. But Monarez was ousted after, among other things, she refused to automatically sign off the committee\u2019s recommendations, according to Dr. Richard Besser, a former CDC acting director who spoke to her.<br \/>As an acting official, federal law limits O\u2019Neill to no more than 210 days heading the agency before he must step aside or be formally nominated to the post.<br \/>Dr. Anne Schuchat, who served twice as acting CDC director, says there are essentially no limits on the powers of the acting agency chiefs, beyond the time constraints.<br \/>\u201cI was told, \u2018You\u2019re the director. Do what you need to do,\u2019\u201d Schuchat said.Dueling health roles<br \/>Both of O\u2019Neill\u2019s roles at HHS and CDC are demanding, full-time jobs that would be extremely challenging for one person to do simultaneously, Schuchat said.<br \/>\u201cBut if the goal is to have an acting CDC director fulfill a predetermined decision about vaccines, it\u2019s a different story,\u201d Schuchat said.<br \/>It won\u2019t help O\u2019Neill that there was an exodus this week of four veteran CDC center directors, leaving the agency with few leaders who have a background in medicine, science or public health crisis management, she added.<br \/>The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute\u2019s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>President Donald Trump has picked Jim O\u2019Neill, a former investor and critic of health regulations serving under Health Secretary Robert F. Kennedy Jr., to take control of the CDC, following a tumultuous week in which the agency&rsquo;s director was forced out. President Donald Trump has picked Jim O\u2019Neill, a former investor and critic of health [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":3302049,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[105],"tags":[],"_links":{"self":[{"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/posts\/3302050"}],"collection":[{"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/comments?post=3302050"}],"version-history":[{"count":0,"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/posts\/3302050\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/media\/3302049"}],"wp:attachment":[{"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/media?parent=3302050"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/categories?post=3302050"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/nhub.news\/fr\/wp-json\/wp\/v2\/tags?post=3302050"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}